Loading Events

Amgen-CBSA Virtual Healthcare Innovation Event

Tuesday, Mar 23, 2021



Amgen-CBSA Virtual Healthcare Innovation Event

The Healthcare Innovation Event, sponsored by Amgen in partnership with Colorado BioScience Association will engage with Colorado’s life sciences and healthcare ecosystem to feature speakers addressing healthcare disparities of underrepresented populations in cardiovascular and metabolic diseases.



2:00-2:20 Welcome & Opening Remarks, Equity in Public Health
Robert Franklin, II, Diversity, Health Equity & Inclusion Program Manager, Children’s Hospital Colorado

2:20-2:50 – Amgen’s Mission to Serve Patients
Simon Jackson, PhD, Executive Director, Cardiometabolic Disorders, Amgen

2:50-3:20 – Underrepresented Populations in Studies of Cardio-metabolic Disease
Ray Estacio, MD, Co-Director , Community Health, CPC Clinical Research; Associate Professor of Medicine, CU
Judy Hsia, MD, Senior Director, CPC Clinical Research; Associate Professor of Medicine, CU

3:20-4:00 – Pitch Event – Four Colorado companies will pitch for the opportunity to receive Amgen mentoring and a $5,000 Amgen grant

  • Anushree Chatterjee, Co-founder & CEO, Sachi Bioworks, Inc. – Genetic Tools and Therapeutics company that develops nucleic acid molecules to target any gene in any organism
  • Lyndsey Linke, CEO, SiVEC Biotechnologies – R&D company that develops manufacture and delivery of nucleic acids and holds a portfolio in human and animal health
  • Alan Sage, CEO, Vaporox,  Inc. – Breakthrough technology for treating diabetic foot ulcers
  • Xuedong Liu, President, Vesicle Therapeutics, Inc. – Liu Lab uses uses live-cell microscopy and sequencing-baed techniques to understand the fundamental mechanisms underlying cell signaling networks

Pitch Event Judges:
Chad King, PhD, Executive Director, Research and Site Head, Amgen British Columbia
Dr. Peter Buttrick, Division Head, Cardiology, Senior Associate Dean for Academic Affairs, S. Gilbert Blount Endowed Professor, CU School of Medicine
Kim Muller, ESQ., Executive Director, CU Innovations
Hanadie Yousef, PhD, Scientist, Co-founder and CEO, Juvena Therapeutics

4:05-4:30 – Strengthening Colorado’s Future Workforce: The P-TECH program and St. Vrain Valley School District
Russell Fox, EdD Assistant Principal, Frederick High School

4:30-4:55 – Partnerships That Work: Colorado BioScience Institute + Amgen Foundation + LabxChange
Scott Heimlich, Vice President, Amgen Foundation; Director of Philanthropy, Amgen
Meg John, Vice President, Colorado BioScience Institute

4:55-5:05 – Pitch Winner Announcement & Closing Remarks

Complimentary to CBSA Members/$25 Non Members



Sponsored by:



About Amgen
For 40 years, Amgen has been a pioneer in biotechnology, creating life-changing medicines for patients suffering from some of the world’s most serious, prevalent, and costly diseases. Our 22,000 employees partner with physicians, caregivers, and healthcare systems in more than 100 countries to serve patients with cancer, heart disease, chronic inflammatory diseases, osteoporosis, migraine, and kidney disease.  In addition to our innovative medicines, we offer a number of high-quality biosimilars, providing more treatment options to patients and contributing to the sustainability of healthcare systems. Learn More

Sustaining Sponsor: